Abstract | OBJECTIVE: To compare the effectiveness of oral misoprostol and intravenous oxytocin in reducing blood loss in women undergoing indicated or elective cesarean delivery (CD) under spinal anesthesia. METHODS: In this prospective, double-blind pilot study, 56 parturients who received 5 IU of intravenous oxytocin after cord clamping were randomized to further receive either misoprostol orally and a placebo infusion intravenously or placebo orally and an oxytocin infusion intravenously. RESULTS: After adjustment was made for the sonographically estimated amniotic fluid volume, there was no statistical difference in blood loss between the 2 groups (mean+/-S.D., 1083+/-920 mL in the oxytocin group vs. 970+/-560 mL in the misoprostol group; P=.59). CONCLUSION:
|
Authors | O Lapaire, M C Schneider, M Stotz, D V Surbek, W Holzgreve, I M Hoesli |
Journal | International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
(Int J Gynaecol Obstet)
Vol. 95
Issue 1
Pg. 2-7
(Oct 2006)
ISSN: 0020-7292 [Print] United States |
PMID | 16934269
(Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Oxytocics
- Misoprostol
- Oxytocin
|
Topics |
- Administration, Oral
- Adult
- Cesarean Section
(methods)
- Double-Blind Method
- Female
- Hemostasis, Surgical
(methods)
- Humans
- Injections, Intravenous
- Misoprostol
(therapeutic use)
- Oxytocics
(therapeutic use)
- Oxytocin
(therapeutic use)
- Pilot Projects
- Postpartum Hemorrhage
(drug therapy)
- Pregnancy
- Prospective Studies
- Treatment Outcome
|